Detalhe da pesquisa
1.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37947974
2.
Microsurgical training curriculum in a gynecological breast cancer center: a benefit for patients and surgeons?
Arch Gynecol Obstet
; 309(1): 281-286, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37644236
3.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32657944
4.
First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer.
Arch Gynecol Obstet
; 302(6): 1461-1467, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32902674
5.
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
Ann Surg Oncol
; 26(12): 3892-3901, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31350646
6.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38093166
7.
The impact of EndoPredict ® on decision making with increasing oncological work experience: can overtreatment be avoided?
Arch Gynecol Obstet
; 299(5): 1437-1442, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30783737
8.
Reconstructive breast surgery with partially absorbable bi-component Seragyn® BR soft mesh: an outcome analysis.
Arch Gynecol Obstet
; 298(4): 755-761, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30083777
9.
Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
Breast Cancer Res Treat
; 163(3): 495-506, 2017 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28315068
10.
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.
Lancet Oncol
; 17(3): 345-356, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26869049
11.
Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.
J Transl Med
; 14(1): 112, 2016 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27142386
12.
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.
Br J Cancer
; 113(11): 1565-70, 2015 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26554654
13.
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
Breast Cancer Res Treat
; 152(2): 377-87, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26109347
14.
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
Breast Cancer Res Treat
; 150(1): 127-39, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25677740
15.
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
Lancet Oncol
; 15(7): 747-56, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24794243
16.
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.
BMC Cancer
; 14: 66, 2014 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-24499441
17.
Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer.
Eur J Nucl Med Mol Imaging
; 40(11): 1656-61, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23754763
18.
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.
JAMA Surg
; 158(8): 807-815, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37285140
19.
Does the Duration of Perioperative Antibiotic Prophylaxis Influence the Incidence of Postoperative Surgical-Site Infections in Implant-Based Breast Reconstruction in Women with Breast Cancer? A Retrospective Study.
Plast Reconstr Surg
; 149(4): 617e-628e, 2022 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35103626
20.
Impact of demographic and perioperative risk factors on complication rates in skin-sparing/nipple-sparing mastectomy with implant-based reconstruction using titanized polypropylene mesh (TiLOOP® Bra).
Surg Oncol
; 40: 101675, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34871867